Larry Henderson
Family Medicine · Lucedale, MSNPI 1215976022
Payments from drug & device makers
Across 99 payments — averaging $11.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$307
- Pfizer$199
- Novo Nordisk$177
- Takeda Pharmaceuticals U.S.A., Inc.$93
- AbbVie$70
- Sunovion Pharmaceuticals Inc.$51
- plus $276 from 14 others
What the payments were for
- Food & beverage$1,14798%
- Education$252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $307 |
| Pfizer | 26 | $199 |
| Novo Nordisk | 12 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $93 |
| AbbVie(2 entities) | 5 | $70 |
| Sunovion Pharmaceuticals Inc. | 4 | $51 |
| AstraZeneca | 3 | $45 |
| Amgen | 2 | $34 |
| GSK | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Boston Scientific | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
| Merck | 1 | $11 |
| Phathom Pharmaceuticals, Inc. | 2 | $11 |
How this compares
$1,172 in reported general payments places this provider in the 60th percentile of 971 family medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 199 | $223,835 |
| TrulicityDulaglutide | 96 | $113,238 |
| LinzessLinaclotide | 141 | $81,143 |
| EliquisApixaban | 86 | $74,254 |
| JardianceEmpagliflozin | 74 | $70,963 |
| XareltoRivaroxaban | 116 | $62,420 |
| JanuviaSitagliptin Phosphate | 95 | $61,088 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $41,730 |
| XifaxanRifaximin | 11 | $34,311 |
| RybelsusSemaglutide | 11 | $25,102 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $23,153 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $21,741 |
| EntrestoSacubitril/Valsartan | 24 | $21,066 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 29 | $20,546 |
| Sucralfate | 225 | $20,347 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $177 | $248,938210 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $13 | $124,706108 claims |
| MerckJanuvia, Janumet | $11 | $82,829111 claims |
| AbbVieLinzess | $70 | $81,143141 claims |
| Johnson & JohnsonXarelto, Invokana | $15 | $74,344127 claims |
| PfizerEliquis | $199 | $74,25486 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $31 | $52,28264 claims |
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere | $45 | $50,704115 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $307 | $34,31111 claims |
| AmgenProlia | $34 | $17,88611 claims |
| Astellas Pharma US IncMyrbetriq | $12 | $14,48816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Lucedale
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
- Keith StokesLexington$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.